BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32284333)

  • 1. STING Sensing of Murine Cytomegalovirus Alters the Tumor Microenvironment to Promote Antitumor Immunity.
    Wilski NA; Stotesbury C; Del Casale C; Montoya B; Wong E; Sigal LJ; Snyder CM
    J Immunol; 2020 Jun; 204(11):2961-2972. PubMed ID: 32284333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the Tumor.
    Wilski NA; Del Casale C; Purwin TJ; Aplin AE; Snyder CM
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
    Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment.
    Chelvanambi M; Fecek RJ; Taylor JL; Storkus WJ
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33526609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STING induces early IFN-β in the liver and constrains myeloid cell-mediated dissemination of murine cytomegalovirus.
    Tegtmeyer PK; Spanier J; Borst K; Becker J; Riedl A; Hirche C; Ghita L; Skerra J; Baumann K; Lienenklaus S; Doering M; Ruzsics Z; Kalinke U
    Nat Commun; 2019 Jun; 10(1):2830. PubMed ID: 31249303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells.
    Miao L; Qi J; Zhao Q; Wu QN; Wei DL; Wei XL; Liu J; Chen J; Zeng ZL; Ju HQ; Luo HY; Xu RH
    Theranostics; 2020; 10(2):498-515. PubMed ID: 31903134
    [No Abstract]   [Full Text] [Related]  

  • 7. STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer.
    Vonderhaar EP; Barnekow NS; McAllister D; McOlash L; Eid MA; Riese MJ; Tarakanova VL; Johnson BD; Dwinell MB
    Cell Mol Gastroenterol Hepatol; 2021; 12(1):41-58. PubMed ID: 33548597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus infection is controlled by hematopoietic and stromal cell sensing of murine cytomegalovirus through STING.
    Piersma SJ; Poursine-Laurent J; Yang L; Barber GN; Parikh BA; Yokoyama WM
    Elife; 2020 Jul; 9():. PubMed ID: 32723479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The herpesviral antagonist m152 reveals differential activation of STING-dependent IRF and NF-κB signaling and STING's dual role during MCMV infection.
    Stempel M; Chan B; Juranić Lisnić V; Krmpotić A; Hartung J; Paludan SR; Füllbrunn N; Lemmermann NA; Brinkmann MM
    EMBO J; 2019 Mar; 38(5):. PubMed ID: 30696688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus.
    Cocita C; Guiton R; Bessou G; Chasson L; Boyron M; Crozat K; Dalod M
    PLoS Pathog; 2015 May; 11(5):e1004897. PubMed ID: 25954804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cGAS-STING Signaling Regulates Initial Innate Control of Cytomegalovirus Infection.
    Lio CW; McDonald B; Takahashi M; Dhanwani R; Sharma N; Huang J; Pham E; Benedict CA; Sharma S
    J Virol; 2016 Sep; 90(17):7789-97. PubMed ID: 27334590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus Calmette-Guérin immunotherapy induces an efficient antitumor response to control murine melanoma depending on MyD88 signaling.
    Borges VM; Marinho FV; Caldeira CVA; de Queiroz NMGP; Oliveira SC
    Front Immunol; 2024; 15():1380069. PubMed ID: 38835781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.
    Ohkuri T; Ghosh A; Kosaka A; Zhu J; Ikeura M; David M; Watkins SC; Sarkar SN; Okada H
    Cancer Immunol Res; 2014 Dec; 2(12):1199-208. PubMed ID: 25300859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.
    Anghelina D; Lam E; Falck-Pedersen E
    J Virol; 2016 Jul; 90(13):5915-27. PubMed ID: 27076643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Chemokine Receptor CXCR3 Promotes CD8
    Caldeira-Dantas S; Furmanak T; Smith C; Quinn M; Teos LY; Ertel A; Kurup D; Tandon M; Alevizos I; Snyder CM
    J Immunol; 2018 Feb; 200(3):1133-1145. PubMed ID: 29288198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous Immunity and Persistent Murine Cytomegalovirus Infection.
    Che JW; Daniels KA; Selin LK; Welsh RM
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation.
    Lemos H; Mohamed E; Huang L; Ou R; Pacholczyk G; Arbab AS; Munn D; Mellor AL
    Cancer Res; 2016 Apr; 76(8):2076-81. PubMed ID: 26964621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection.
    Munks MW; Pinto AK; Doom CM; Hill AB
    J Immunol; 2007 Jun; 178(11):7235-41. PubMed ID: 17513772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection.
    Dorner BG; Smith HR; French AR; Kim S; Poursine-Laurent J; Beckman DL; Pingel JT; Kroczek RA; Yokoyama WM
    J Immunol; 2004 Mar; 172(5):3119-31. PubMed ID: 14978118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.
    MacDonald MR; Li XY; Stenberg RM; Campbell AE; Virgin HW
    J Virol; 1998 Jan; 72(1):442-51. PubMed ID: 9420244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.